Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
OSIRIS THERAPEUTICS (OSIR)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: OSIR
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Graft-Versus-Host Disease: Failures and Future Opportunities
Dec 10
•
Michael Becker
•
Comment!
Expiration Trade Behind Osiris Activity
Nov 20
•
optionMONSTER
•
Comment!
Tuesday Options Recap
Nov 3
•
Frederic Ruffy
•
Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Closing Update: Stocks String Together 3 Straight Wins, Commodities Gain
Sep 8
•
Midnight Trader
•
4 Comments
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 2
Aug 27
•
M. E. Garza
•
3 Comments
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 1
Aug 27
•
M. E. Garza
•
1 Comment
'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
Aug 25
•
Justin M. Hall
•
5 Comments
Monday Options Recap
Aug 24
•
Frederic Ruffy
•
Comment!
Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results
Jul 29
•
Justin M. Hall
•
8 Comments
Spectrum Pharmaceuticals: Outlook Remains Very Promising
Jul 27
•
Justin M. Hall
•
20 Comments
Adult Stem Cell Drugs and Therapies Are the Next Big Market
Jun 18
•
M. E. Garza
•
10 Comments
Stem Cell Index Surges in Past Week
May 11
•
Mike Havrilla
•
3 Comments
Optimistic on Osiris Therapeutics
May 8
•
Zacks.com
•
Comment!
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
Apr 23
•
Mike Havrilla
•
1 Comment
Banking on NeoStem
Apr 12
•
Mike Havrilla
•
4 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2
•
Mark Cifra
•
5 Comments
8 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week
Mar 30
•
J Clinton Hill
•
Comment!
FDA and Clinical Trial Updates: Osiris Sees Flaw in Crohn's Disease Trial
Mar 29
•
Mike Havrilla
•
2 Comments
Osiris Hits a Speedbump in Crohn's Program
Mar 27
•
Zacks.com
•
2 Comments
With Funding Ban Lifted, Stem Cell Index Soars
Mar 10
•
Mike Havrilla
•
Comment!
12 Stem Cell Stocks - Updated
Mar 9
•
Stockerblog
•
8 Comments
Know Your Options When Investing in Biotech Stocks
Mar 2
•
Zacks.com
•
5 Comments
Osiris Therapeutics Enters a New Age of Pharma Risk and Profit Share
Feb 8
•
Dusan Bogunovic
•
1 Comment
Little Rays of Sunshine in the Markets
Feb 6
•
Richard Shaw
•
3 Comments
Trading the Trials and FDA Decision Calendar
Jan 26
•
Mike Havrilla
•
1 Comment
Stem Cell Research Stocks Soar as Obama Takes Office
Jan 25
•
Mike Havrilla
•
5 Comments
20 Emerging Healthcare Stocks to Watch in '09
Jan 11
•
Mike Havrilla
•
4 Comments
9 Possible Pharma Deals for 2009
Jan 8
•
Zacks.com
•
7 Comments
Stem Cell and Regenerative Medicine Stocks Surge in December
Dec 20, 2008
•
Mike Havrilla
•
7 Comments
Healthcare: Investing Trends for 2009
Dec 19, 2008
•
Mike Havrilla
•
3 Comments
Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results
Dec 9, 2008
•
Mike Havrilla
•
Comment!
ETF Ideas Poised to Benefit from Pending Healthcare Reform
Dec 8, 2008
•
Mike Havrilla
•
1 Comment
New Emerging Biotech and Pharma Company Index
Nov 23, 2008
•
Mike Havrilla
•
3 Comments
Regenerative Medicine: Big Pharma's Next Frontier
Nov 19, 2008
•
Mike Havrilla
•
2 Comments
ETFI Global Healthcare Sector PerfomIdex
Nov 9, 2008
•
Mike Havrilla
•
1 Comment
Genzyme and Osiris Get Together on Stem Cells
Nov 5, 2008
•
Mike Huckman
•
Comment!
Cosmetic and Reconstructive Medicine ETF Outpaces Healthcare Sector
Nov 2, 2008
•
Mike Havrilla
•
Comment!
Three Biotechs Hitting New 52-Week Highs
Sep 24, 2008
•
John C. Lee
•
5 Comments
10 Biotechs in Stem Cells that Could Profit Under the Democrats
Jun 1, 2008
•
Ketan Desai
•
16 Comments
1
2
Next Page